Jaume Pons - Jul 25, 2023 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
President & CEO, Director
Signature
/s/ Peter Garcia, by power of attorney
Stock symbol
ALXO
Transactions as of
Jul 25, 2023
Transactions value $
$0
Form type
4
Date filed
7/27/2023, 04:11 PM
Previous filing
Jul 5, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Award $0 +89K +16.59% $0.00 626K Jul 25, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option (right to buy) Award $0 +282K $0.00 282K Jul 25, 2023 Common Stock 282K $5.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023.
F2 Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023.